Gray matter differences associated with menopausal hormone therapy in menopausal women: a DARTEL-based VBM study
Paciuc, J. Hormone therapy in menopause. Adv. Exp. Med. Biol. 1242, 89–120 (2020).
Takahashi, T. A. & Johnson, K. M. Menopause. Med. Clin. N. Am. 99, 521–534 (2015).
Baber, R. J., Panay, N. & Fenton, A. 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy. Climacteric 19, 109–150 (2016).
Palacios, S., Stevenson, J. C., Schaudig, K., Lukasiewicz, M. & Graziottin, A. Hormone therapy for first-line management of menopausal symptoms: Practical recommendations. Womens Health 15, 1745506519864009 (2019).
Kim, T. H., Kang, H. K., Park, K. & Jeong, G. W. Localized brain metabolite changes during visual sexual stimulation in postmenopausal women: A pilot study using functional magnetic resonance spectroscopy. Menopause 21, 59–66 (2014).
Kim, G. W., Park, K. & Jeong, G. W. Effects of sex hormones and age on brain volume in post-menopausal women. J. Sex. Med. 15, 662–670 (2018).
Rahman, A. et al. Sex and gender driven modifiers of Alzheimer’s: The role for estrogenic control across age, race, medical, and lifestyle risks. Front. Aging Neurosci. 11, 315 (2019).
Hagemann, G. et al. Changes in brain size during the menstrual cycle. PLoS ONE 6, e14655 (2011).
Ossewaarde, L. et al. Menstrual cycle-related changes in amygdala morphology are associated with changes in stress sensitivity. Hum. Brain Mapp. 34, 1187–1193 (2013).
Lisofsky, N. et al. Hippocampal volume and functional connectivity changes during the female menstrual cycle. Neuroimage 118, 154–162 (2015).
Protopopescu, X. et al. Hippocampal structural changes across the menstrual cycle. Hippocampus 18, 985–988 (2008).
Petersen, N., Touroutoglou, A., Andreano, J. M. & Cahill, L. Oral contraceptive pill use is associated with localized decreases in cortical thickness. Hum. Brain Mapp. 36, 2644–2654 (2015).
De Bondt, T. et al. Regional gray matter volume differences and sex-hormone correlations as a function of menstrual cycle phase and hormonal contraceptives use. Brain Res. 1530, 22–31 (2013).
Pletzer, B., Kronbichler, M. & Kerschbaum, H. Differential effects of androgenic and anti-androgenic progestins on fusiform and frontal gray matter volume and face recognition performance. Brain Res. 1596, 108–115 (2015).
Albert, K. et al. Estrogen enhances hippocampal gray-matter volume in young and older postmenopausal women: A prospective dose-response study. Neurobiol. Aging 56, 1–6 (2017).
Menopause Advisory Panel. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause 29, 767–794 (2022).
Hickey, M., Elliott, J. & Davison, S. L. Hormone replacement therapy. BMJ 344, e763 (2012).
Song, Y. J. et al. The effect of estrogen replacement therapy on Alzheimer’s disease and Parkinson’s disease in postmenopausal women: A meta-analysis. Front. Neurosci. 14, 157 (2020).
Ibrahim, A. W., Sodipo, O. A., Mshelia, I. A. & Machina, B. K. Hormone replacement therapy and Alzheimer’s disease in older women: A systematic review of literature. J. Neurosci. Behav. Health 10, 1–8 (2018).
Savolainen-Peltonen, H. et al. Use of postmenopausal hormone therapy and risk of Alzheimer’s disease in Finland: Nationwide case-control study. BMJ 364, l665 (2019).
Gambacciani, M. et al. Menopause and hormone replacement therapy: The 2017 Recommendations of the Italian Menopause Society. Minerva Ginecol. 70, 27–34 (2018).
Nudy, M., Chinchilli, V. M. & Foy, A. J. A systematic review and meta-regression analysis to examine the “timing hypothesis” of hormone replacement therapy on mortality, coronary heart disease, and stroke. IJC Heart Vasc. 22, 123–131 (2019).
Gambacciani, M., Cagnacci, A. & Lello, S. Hormone replacement therapy and prevention of chronic conditions. Climacteric 22, 303–306 (2019).
Goto, M. et al. 3 Tesla MRI detects accelerated hippocampal volume reduction in postmenopausal women. J. Magn. Reson. Imaging 33, 48–53 (2011).
Boyle, C. P. et al. Estrogen, brain structure, and cognition in postmenopausal women. Hum. Brain Mapp. 42, 24–35 (2021).
Resnick, S. M. et al. Postmenopausal hormone therapy and regional brain volumes: The WHIMS-MRI Study. Neurology 72, 135–142 (2009).
Russell, J. K., Jones, C. K. & Newhouse, P. A. The role of estrogen in brain and cognitive aging. Neurotherapeutics 16, 649–665 (2019).
Boccardi, M. et al. Effects of hormone therapy on brain morphology of healthy postmenopausal women: A Voxel-based morphometry study. Menopause 13, 584–591 (2006).
Lord, C., Buss, C., Lupien, S. J. & Pruessner, J. C. Hippocampal volumes are larger in postmenopausal women using estrogen therapy compared to past users, never users and men: A possible window of opportunity effect. Neurobiol. Aging 29, 95–101 (2008).
Erickson, K. I. et al. Selective sparing of brain tissue in postmenopausal women receiving hormone replacement therapy. Neurobiol. Aging 26, 1205–1213 (2005).
Lord, C., Engert, V., Lupien, S. J. & Pruessner, J. C. Effect of sex and estrogen therapy on the aging brain: A voxel-based morphometry study. Menopause 17, 846–851 (2010).
Kim, T. H., Kim, S. K. & Jeong, G. W. Cerebral gray matter volume variation in female-to-male transsexuals: A voxel-based morphometric study. NeuroReport 26, 1119–1125 (2015).
Mott, N. N. & Pak, T. R. Estrogen signaling and the aging brain: Context-dependent considerations for postmenopausal hormone therapy. ISRN Endocrinol. 2013, 814690 (2013).
Bustamante-Barrientos, F. A. et al. The impact of estrogen and estrogen-like molecules in neurogenesis and neurodegeneration: Beneficial or harmful?. Front. Cell. Neurosci. 15, 636176 (2021).
Fink, G., Sumner, B. E., Rosie, R., Grace, O. & Quinn, J. P. Estrogen control of central neurotransmission: Effect on mood, mental state, and memory. Cell. Mol. Neurobiol. 16, 325–344 (1996).
Comasco, E., Frokjaer, V. G. & Sundström-Poromaa, I. Functional and molecular neuroimaging of menopause and hormone replacement therapy. Front. Neurosci. 8, 388 (2014).
Khan, M. M., Dhandapani, K. M., Zhang, Q. G. & Brann, D. W. Estrogen regulation of spine density and excitatory synapses in rat prefrontal and somatosensory cerebral cortex. Steroids 78, 614–623 (2013).
Bayer, U. & Hausmann, M. Hormone therapy in postmenopausal women affects hemispheric asymmetries in fine motor coordination. Horm. Behav. 58, 450–456 (2010).
Maki, P. M. et al. Perimenopausal use of hormone therapy is associated with enhanced memory and hippocampal function later in life. Brain Res. 1379, 232–243 (2011).
Maki, P. M. & Resnick, S. M. Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition. Neurobiol. Aging 21, 373–383 (2000).
Resnick, S. M., Maki, P. M., Golski, S., Kraut, M. A. & Zonderman, A. B. Effects of estrogen replacement therapy on PET cerebral blood flow and neuropsychological performance. Horm. Behav. 34, 171–182 (1998).
Neufang, S. et al. Sex differences and the impact of steroid hormones on the developing human brain. Cereb. Cortex 19, 464–473 (2009).
Weiss, G., Skurnick, J. H., Goldsmith, L. T., Santoro, N. F. & Park, S. J. Menopause and hypothalamic-pituitary sensitivity to estrogen. JAMA 292, 2991–2996 (2004).
Heffner, L. J. & Schust, D. J. The Reproductive System at a Glance 4th edn. (Wiley-Blackwell, 2014).
Ashburner, J. & Friston, K. J. Diffeomorphic registration using geodesic shooting and Gauss-Newton optimisation. Neuroimage 55, 954–967 (2011).
Good, C. D. et al. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 14, 21–36 (2001).
Reddan, M. C., Lindquist, M. A. & Wager, T. D. Effect size estimation in neuroimaging. JAMA Psychiat. 74, 207–208 (2017).